Your browser doesn't support javascript.
loading
Patterns of relapse in poor-prognosis germ-cell tumours in the GETUG 13 trial: Implications for assessment of brain metastases.
Loriot, Y; Pagliaro, L; Fléchon, A; Mardiak, J; Geoffrois, L; Kerbrat, P; Chevreau, C; Delva, R; Rolland, F; Theodore, C; Roubaud, G; Gravis, G; Eymard, J C; Malhaire, J P; Linassier, C; Habibian, M; Martin, A L; Journeau, F; Reckova, M; Logothetis, C; Laplanche, A; Le Teuff, G; Culine, S; Fizazi, K.
Affiliation
  • Loriot Y; Gustave Roussy, Université Paris-Saclay, Département de Médecine Oncologique, Villejuif, F-94805, France. Electronic address: Yohann.loriot@gustaveroussy.fr.
  • Pagliaro L; Mayo Clinic College of Medicine, Mayo Clinic Cancer Center, Rochester, MN, USA.
  • Fléchon A; Centre Léon Bérard, Department of Medical Oncology, Lyon, France.
  • Mardiak J; National Cancer Institute, Bratislava, Slovakia.
  • Geoffrois L; Centre Alexis Vautrin, Department of Cancer Medicine, Nancy, France.
  • Kerbrat P; Centre Eugène Marquis, Department of Cancer Medicine, Rennes, France.
  • Chevreau C; Centre Claudius Regaud, IUCT Department of Medical Oncology, Toulouse, France.
  • Delva R; Institut de Cancérologie de l'Ouest, Department of Cancer Medicine, Angers, France.
  • Rolland F; Institut de Cancérologie de l'Ouest, Department of Cancer Medicine, Nantes, France.
  • Theodore C; Hopital Foch, Department of Cancer Medicine, Suresnes, France.
  • Roubaud G; Institut Bergonié, Department of Medical Oncology, Bordeaux, France.
  • Gravis G; Institut Paoli Calmette, Department of Cancer Medicine, Marseille, France.
  • Eymard JC; Centre Jean Godinot, Department of Cancer Medicine, Reims, France.
  • Malhaire JP; Centre Hospitalo-Universitaire, Department of Cancer Medicine, Brest, France.
  • Linassier C; Centre Hospitalo-Universitaire, Department of Cancer Medicine, Tours, France.
  • Habibian M; Unicancer, Paris, France.
  • Martin AL; Unicancer, Paris, France.
  • Journeau F; Gustave Roussy, Université Paris-Saclay, Département d'épidémiologie et de statistiques, Villejuif, F-94805, France.
  • Reckova M; National Cancer Institute, Bratislava, Slovakia.
  • Logothetis C; University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
  • Laplanche A; Gustave Roussy, Université Paris-Saclay, Département d'épidémiologie et de statistiques, Villejuif, F-94805, France.
  • Le Teuff G; Gustave Roussy, Université Paris-Saclay, Département d'épidémiologie et de statistiques, Villejuif, F-94805, France; CESP, INSERM, Université Paris-Saclay, Univ. Paris-Sud, UVSQ, Villejuif, France.
  • Culine S; Hôpital Saint Louis, Department of Cancer Medicine, Paris, France.
  • Fizazi K; Gustave Roussy, Université Paris-Saclay, Département de Médecine Oncologique, Villejuif, F-94805, France.
Eur J Cancer ; 87: 140-146, 2017 12.
Article in En | MEDLINE | ID: mdl-29149760
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Testicular Neoplasms / Brain Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Neoplasms, Germ Cell and Embryonal Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Screening_studies Limits: Humans / Male Country/Region as subject: America do norte / Europa Language: En Journal: Eur J Cancer Year: 2017 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Testicular Neoplasms / Brain Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Neoplasms, Germ Cell and Embryonal Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Screening_studies Limits: Humans / Male Country/Region as subject: America do norte / Europa Language: En Journal: Eur J Cancer Year: 2017 Type: Article